Emapalumab for severe cytokine release syndrome in solid tumor CAR-T: a case report
{{output}}
Chimeric Antigen Receptor T (CAR-T) cell therapy significantly and rapidly changed the treatment paradigm for lymphoma, myeloma and leukemia, and the recent approvals of the first cellular immunotherapies in melanoma and synovial sarcoma demonstrate the potent... ...
